BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31594734)

  • 1. Focal Laser Ablation Versus Radical Prostatectomy for Localized Prostate Cancer: Survival Outcomes From a Matched Cohort.
    Zheng X; Jin K; Qiu S; Han X; Liao X; Yang L; Wei Q
    Clin Genitourin Cancer; 2019 Dec; 17(6):464-469.e3. PubMed ID: 31594734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.
    Bandini M; Marchioni M; Preisser F; Zaffuto E; Tian Z; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2018 Sep; 36(9):1399-1407. PubMed ID: 29717358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
    Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Therapy Improves Survival in Metastatic Prostate Cancer.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer.
    Chierigo F; Wenzel M; Würnschimmel C; Flammia RS; Horlemann B; Tian Z; Saad F; Chun FKH; Graefen M; Gallucci M; Shariat SF; Mantica G; Borghesi M; Suardi N; Terrone C; Karakiewicz PI
    J Urol; 2022 Feb; 207(2):375-384. PubMed ID: 34555930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
    Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer.
    Zhou X; Jin K; Qiu S; Jin D; Liao X; Tu X; Zheng X; Li J; Yang L; Wei Q
    Sci Rep; 2020 Jun; 10(1):9112. PubMed ID: 32499484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study.
    Jin K; Qiu S; Jin H; Zheng X; Zhou X; Jin D; Li J; Yang L; Wei Q
    Clin Genitourin Cancer; 2020 Dec; 18(6):e705-e722. PubMed ID: 32763123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Oncological Outcomes of Cryoablation vs. Radical Prostatectomy in Low-Intermediate Risk Localized Prostate Cancer.
    Guo XX; Liu SJ; Wang M; Hou HM; Wang X; Zhang ZP; Liu M; Wang JY
    Front Oncol; 2020; 10():1489. PubMed ID: 32983986
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy.
    Wenzel M; Würnschimmel C; Chierigo F; Tian Z; Shariat SF; Terrone C; Saad F; Tilki D; Graefen M; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
    Prostate; 2021 Aug; 81(11):728-735. PubMed ID: 34010465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the Survival Outcomes of Radical Prostatectomy
    Guo X; Xia H; Su X; Hou H; Zhong Q; Wang J
    Front Oncol; 2021; 11():797462. PubMed ID: 34900748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer?
    Jin K; Qiu S; Li J; Zheng X; Tu X; Liao X; Yang Y; Yang L; Wei Q
    Cancer Med; 2019 Jul; 8(7):3370-3378. PubMed ID: 31066510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes of locally advanced prostate cancer in patients aged < 50 years after local therapy in the contemporary US population.
    Sheng W; Zhang H; Lu Y
    Int Urol Nephrol; 2018 Aug; 50(8):1435-1444. PubMed ID: 29982959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer.
    Preisser F; Mazzone E; Knipper S; Nazzani S; Bandini M; Shariat SF; Tian Z; Saad F; Montorsi F; Zorn KC; Graefen M; Tilki D; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Feb; 17(1):e130-e139. PubMed ID: 30366880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
    Thomsen FB; Røder MA; Jakobsen H; Langkilde NC; Borre M; Jakobsen EB; Frey A; Lund L; Lunden D; Dahl C; Brasso K
    Clin Genitourin Cancer; 2019 Aug; 17(4):e814-e821. PubMed ID: 31196798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.
    Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Pompe RS; Montorsi F; Saad F; Abdollah F; Steuber T; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):399-406. PubMed ID: 29306731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.